Daniel Castellano

Researcher Next ID · RN-003072

Researcher · Medicine

Madrid, Spain

Not currently recruitingFunding unknown

Research interests

Medicine

Bladder and Urothelial Cancer Treatments

Renal cell carcinoma treatment

Cancer Immunotherapy and Biomarkers

Prostate Cancer Treatment and Research

Urinary and Genital Oncology Studies

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31187-9
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1712126
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)00561-4
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1510665
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
The Lancet · 2011 · https://doi.org/10.1016/s0140-6736(11)61613-9

No projects listed.